Tenon Medical (TNONW) Cash from Financing Activities (2021 - 2026)

Tenon Medical's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 38.22% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $6.6 million (down 58.8% YoY), while the FY2025 annual figure was $9.0 million, down 36.36% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $3.9 million, up from $2.7 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $14.2 million in Q2 2022, with the low at -$59000.0 in Q2 2025.
• The 5-year median for Cash from Financing Activities is $1.4 million (2023), against an average of $3.2 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 10507.14% in 2024, then sank 99.39% in 2025.
• Tenon Medical's Cash from Financing Activities stood at -$25000.0 in 2022, then soared by 5584.0% to $1.4 million in 2023, then tumbled by 91.76% to $113000.0 in 2024, then surged by 2315.93% to $2.7 million in 2025, then soared by 41.65% to $3.9 million in 2026.
• Business Quant data shows TNONW's Cash from Financing Activities at $3.9 million in Q1 2026, $2.7 million in Q4 2025, and $59000.0 in Q3 2025.